Chugai Pharmaceutical Co., Ltd. (CHGCF)
42.57
+7.31
(+20.72%)
USD |
OTCM |
Sep 17, 16:00
Chugai Pharmaceutical Market Cap : 70.04B for Sept. 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 17, 2026 | 70.04B |
| September 16, 2026 | 58.02B |
| September 15, 2026 | 67.75B |
| September 14, 2026 | 71.14B |
| September 11, 2026 | 70.34B |
| September 10, 2026 | 65.57B |
| September 09, 2026 | 68.07B |
| September 08, 2026 | 71.95B |
| September 04, 2026 | 71.31B |
| September 03, 2026 | 72.39B |
| September 02, 2026 | 68.44B |
| September 01, 2026 | 68.12B |
| August 31, 2026 | 72.82B |
| August 28, 2026 | 73.06B |
| August 27, 2026 | 72.04B |
| August 26, 2026 | 70.55B |
| August 25, 2026 | 69.78B |
| August 24, 2026 | 73.85B |
| August 21, 2026 | 69.15B |
| August 20, 2026 | 70.89B |
| August 19, 2026 | 70.46B |
| August 18, 2026 | 68.63B |
| August 17, 2026 | 73.70B |
| August 14, 2026 | 71.11B |
| August 13, 2026 | 71.71B |
| Date | Value |
|---|---|
| August 12, 2026 | 72.32B |
| August 11, 2026 | 70.83B |
| August 10, 2026 | 73.22B |
| August 07, 2026 | 70.56B |
| August 06, 2026 | 71.48B |
| August 05, 2026 | 68.05B |
| August 04, 2026 | 71.86B |
| August 03, 2026 | 69.58B |
| July 31, 2026 | 71.04B |
| July 30, 2026 | 76.62B |
| July 29, 2026 | 69.08B |
| July 28, 2026 | 68.82B |
| July 27, 2026 | 71.45B |
| July 24, 2026 | 79.55B |
| July 23, 2026 | 68.58B |
| July 22, 2026 | 71.81B |
| July 21, 2026 | 72.34B |
| July 20, 2026 | 73.42B |
| July 17, 2026 | 76.44B |
| July 16, 2026 | 72.92B |
| July 15, 2026 | 68.85B |
| July 14, 2026 | 70.54B |
| July 13, 2026 | 72.63B |
| July 10, 2026 | 73.26B |
| July 09, 2026 | 71.93B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 59.78B |
| Daiichi Sankyo Co., Ltd. | 34.30B |
| Eisai Co., Ltd. | 8.937B |
| Santen Pharmaceutical Co., Ltd. | 3.674B |
| Ono Pharmaceutical Co., Ltd. | 7.190B |
Market Cap Related Metrics
| PE Ratio | 22.95 |
| PS Ratio | 8.052 |
| PEG Ratio | 1.484 |
| Price to Book Value | 5.614 |
| Price to Free Cash Flow | 29.94 |
| Price | 42.57 |
| Earnings Yield | 4.36% |
| PEGY Ratio | 1.232 |
| Operating PE Ratio | 15.96 |
| Normalized PE Ratio | 21.91 |